World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
20116
World Ranking
15314
National Ranking
1406

Overview

Hans-Georg Eichler is affiliated with the European Medicines Agency in the United Kingdom. Their research contributions span the intersection of economics, econometrics, finance, and medicine, with particular emphasis on health systems, economic evaluations, and pharmaceutical economics and policy.

The scientific output includes notable papers such as:

  • Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth (2020) published in Clinical Pharmacology & Therapeutics
  • Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative (2020) in Value in Health
  • Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions (2022) published in Nature Communications
  • Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance (2021) in Journal of Comparative Effectiveness Research
  • A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem (2021) in Clinical Pharmacology & Therapeutics

Their frequent co-authors include:

  • Guido Rasi (5 publications)
  • Peter Arlett (4 publications)
  • Wim Goettsch (4 publications)
  • Páll Jónsson (4 publications)
  • Brigitte Schwarzer-Daum (3 publications)

Hans-Georg Eichler publishes regularly in several key scientific venues, including:

  • Clinical Pharmacology & Therapeutics (4 publications)
  • International Journal of Technology Assessment in Health Care (2 publications)
  • European Journal of Internal Medicine (2 publications)
  • Value in Health (1 publication)
  • Nature Communications (1 publication)

The main fields of study consist of:

  • Economics, Econometrics and Finance (19 publications)
  • Medicine (11 publications)

Within these areas, the subfields covered include:

  • Economics and Econometrics (19 publications)
  • Statistics and Probability (5 publications)
  • Statistics, Probability and Uncertainty (3 publications)
  • General Health Professions (3 publications)
  • Public Health, Environmental and Occupational Health (3 publications)

The research topics addressed in their work are:

  • Health Systems, Economic Evaluations, Quality of Life (24 publications)
  • Pharmaceutical Economics and Policy (10 publications)
  • Advanced Causal Inference Techniques (6 publications)
  • Meta-analysis and systematic reviews (6 publications)
  • Statistical Methods in Clinical Trials (4 publications)
  • Medication Adherence and Compliance (4 publications)
  • Healthcare cost, quality, practices (4 publications)

Best Publications

  • Use of Cost‐Effectiveness Analysis in Health‐Care Resource Allocation Decision‐Making: How Are Cost‐Effectiveness Thresholds Expected to Emerge?

    Hans-Georg Eichler;Hans-Georg Eichler;Sheldon X. Kong;William C. Gerth;Panagiotis Mavros

  • bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.

    Burkhard Jansen;Hermine Schlagbauer-Wadl;Bob D. Brown;Robert N. Bryan

  • Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

    Marc L. Berger;Harold Sox;Richard J. Willke;Diana L. Brixner

  • Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis? Systematic Re-Evaluation of Clinical Evidence and Drug Cost Implications

    Olga Geling;Hans-Georg Eichler

  • Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.

    Gu¨nter Klappacher;Patrick Franzen;Doris Haab;Mohammad Mehrabi

  • Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response

    Hans-Georg Eichler;Eric Abadie;Eric Abadie;Alasdair Breckenridge;Bruno Flamion

  • Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension.

    Gabriele Fuchsjäger-Mayrl;Beate Wally;Michael Georgopoulos;Georg Rainer

  • Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

    Hans-Georg Eichler;Francesco Pignatti;Bruno Flamion;Hubert Leufkens

  • Paroxetine decreases platelet serotonin storage and platelet function in human beings.

    Nicole Hergovich;Martin Aigner;Hans‐Georg Eichler;Jesusa Entlicher

  • Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

    Susanne Vrtala;Kora Hirtenlehner;Luca Vangelista;Annalisa Pastore

  • Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin.

    Bernd Jilma;Andrew Blann;Thomas Pernerstorfer;Petra Stohlawetz

  • Evaluation of the Zeiss retinal vessel analyser.

    Kaija Polak;Guido Dorner;Barbara Kiss;Elzbieta Polska

  • Penetration of Moxifloxacin into Peripheral Compartments in Humans

    Markus Müller;Heino Staß;Martin Brunner;Jan G. Möller

  • Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

    Hans-Georg Eichler;Brigitte Bloechl-Daum;Eric Abadie;David Barnett

  • Heparin Blunts Endotoxin-Induced Coagulation Activation

    T. Pernerstorfer;U. Hollenstein;J.-B. Hansen;M. Knechtelsdorfer

  • The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

    A. Ihbe-Heffinger;B. Ehlken;R. Bernard;K. Berger

  • Menstrual cycle-associated changes in blood levels of interleukin-6, α1 acid glycoprotein, and C-reactive protein

    Bernd Jilma;Eva Dirnberger;Isabella Löscher;Anna Rumplmayr

  • Application of microdialysis to clinical pharmacokinetics in humans

    Markus Müller;Rainer Schmid;Apostolos Georgopoulos;Astrid Buxbaum

  • Noninvasive investigations of the normal ocular circulation in humans.

    L Schmetterer;S Dallinger;O Findl;K Strenn

  • Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines Strategy

    Francesca Cerreta;Hans-Georg Eichler;Guido Rasi

Frequent Co-Authors

Leopold Schmetterer
Leopold Schmetterer Nanyang Technological University
Bernd Jilma
Bernd Jilma Medical University of Vienna
Oliver Findl
Oliver Findl Hanusch Hospital
Markus Müller
Markus Müller Medical University of Vienna
Oswald Wagner
Oswald Wagner Medical University of Vienna
Burkhard Jansen
Burkhard Jansen University of British Columbia
Peter Valent
Peter Valent Medical University of Vienna
Klaus Lechner
Klaus Lechner Medical University of Vienna
Hubert G. M. Leufkens
Hubert G. M. Leufkens Utrecht University
Rudolf Valenta
Rudolf Valenta Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a major commitment, there are alternative and complementary career pathways in healthcare available through online degrees. These options can offer greater flexibility, affordability, and in some cases, a faster route to entering the field.

For those interested in healthcare leadership, consider the best online mha programs. Many of these programs are designed for working professionals and provide essential skills in management and policy. Additionally, students searching for cost-effective options can explore the cheapest online master degree in healthcare administration, making advanced education more accessible.

If you prefer a clinical doctorate, accelerated online programs now exist. For advanced practice nurses, a 1 year dnp program online can quickly prepare you for top clinical roles. Future pharmacists can benefit from the convenience of a 3-year online pharmd, allowing faster entry into pharmacy practice.

These online pathways support a diverse range of careers for those devoted to healthcare—offering flexible, accredited, and often more affordable opportunities to achieve your professional goals.

Best Scientists Citing Hans-Georg Eichler

Trending Scientists

Recently Published Articles